Ifosfamide: an old drug recently rediscovered

F Cavalli¹

Affiliations

Comparative Study

F Cavalli. Eur J Cancer Clin Oncol. 1988 Jun.

. 1988 Jun;24(6):959-61.

doi: 10.1016/0277-5379(88)90142-3.

F Cavalli¹

No abstract available

Similar articles

Ifosfamide--pharmacology, safety and therapeutic potential.
Brade WP, Herdrich K, Varini M. Brade WP, et al. Cancer Treat Rev. 1985 Mar;12(1):1-47. doi: 10.1016/0305-7372(85)90011-8. Cancer Treat Rev. 1985. PMID: 3896483 Review. No abstract available.
Ifosfamide in paediatric oncology: tried but not tested?
Shaw PJ, Eden T. Shaw PJ, et al. Lancet. 1990 Apr 28;335(8696):1022-3. doi: 10.1016/0140-6736(90)91076-m. Lancet. 1990. PMID: 1970073 Review. No abstract available.
Ifosfamide vs cyclophosphamide in cancer therapy.
Weiss RB. Weiss RB. Oncology (Williston Park). 1991 May;5(5):67-76; discussion 76-82, 84-6. Oncology (Williston Park). 1991. PMID: 1653004
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
Bramwell VH, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verweij J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, et al. Bramwell VH, et al. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S180-4. Cancer Chemother Pharmacol. 1993. PMID: 8453694 Clinical Trial.
Characterization and chemotherapy of human soft tissue sarcoma (STS) lines grown in nude mice.
Boven E, Calame JJ, Molthoff CF, Pinedo HM. Boven E, et al. Strahlenther Onkol. 1989 Jul;165(7):538-9. Strahlenther Onkol. 1989. PMID: 2546270 No abstract available.